Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

An Acute Gvhd Classification Based on the Dynamic of Gvhd Skin Involvement from Its Appearance to Start of Systemic Treatment

Giuseppe Milone, Salvatore Leotta, Sara Frazzetto, Giulia Giuffrida, Giulio Antonio Milone, Sebastiano Fiore, Benedetta Esposito, Giordana Brunetti, Andrea Spadaro, Maria Grazia Camuglia, Alessandra Cupri

Blood (2023) 142 (Supplement 1): 7005.

https://doi.org/10.1182/blood-2023-172724

Published: 2023

Journal Articles

Isavuconazole Prophylaxis during Early Phases of Allogeneic HSC Transplantation Is Not Associated to an Increase Need of Cyclosporin-a Dose Modification

Alessandra Cupri, MD, Salvatore Leotta, MD, Uros Markovic, MD, Maria Grazia Camuglia, PhD, Giulio Antonio Milone, MD, Angelo Curto Pelle, MD, Valerio Leotta, MD, Mary Ann Di Giorgio, MD, Anna Bulla, MD, Di Marco Anna Lia, PhD, Gaetano Moschetti, MD, Giuseppe Milone, MD PhD

Blood (2019) 134 (Supplement_1): 3271.

https://doi.org/10.1182/blood-2019-127120

Published: 2019

Journal Articles

Red Cell Distribution Width (RDW) As Prognostic Factor in Acute Leukemia Patients Undergoing Allogeneic Hematopoietic Transplantation

Giuseppe Milone, MDPhD, Annalia DiMarco, Giuseppe Sapienza, Salvatore Leotta, Luca Scalise, Carla Consoli, Maria Cristina Pirosa, Alessandra Cupri, Gaetano Moschetti, Maria Grazia Camuglia, Maria Sciacca, AnnaElisa Marchese, PhD

Blood (2017) 130 (Supplement 1): 5098.

https://doi.org/10.1182/blood.V130.Suppl_1.5098.5098

Published: 2017

Journal Articles

High Level of IL-2-Receptor and of TIM-3 in Plasma at Day +18 after Allogeneic Transplantation Can Identify Early Patients at Risk for Treatment Related Mortality

Giuseppe Milone, MDPhD, Viviana Frontini, Alessandra Cupri, Salvatore Leotta, Annalia DiMarco, Carla Consoli, Luca Scalise, Giuseppe Sapienza, Gaetano Moschetti, Giuseppe Avola, Andrea Spadaro, AnnaElisa Marchese, PhD

Blood (2017) 130 (Supplement 1): 4497.

https://doi.org/10.1182/blood.V130.Suppl_1.4497.4497

Published: 2017

Journal Articles

High BCR-ABL/GUS IS Levels at Diagnosis Are Associated with Unfavorable Responses to Standard Dose Imatinib

Blood (2015) 126 (23): 4049.

https://doi.org/10.1182/blood.V126.23.4049.4049

Published: 2015

Journal Articles

Results and Cost Effectiveness of "on-Demand" Plerixafor Added to Chemotherapy and Granulocyte Colony-Stimulating Factor for Peripheral Blood Stem Cell Mobilization in Multiple Myeloma

Giuseppe Milone, MD, Massimo Martino, Annalia Di Marco, BS, Salvatore Leotta, MD, Andrea Spadaro, MD, Mara Morelli, MD, Giuseppe Avola, Maria Grazia Camuglia, Alessandra Cupri, MD, Valentina Zammit, MD, Potito Rosario Scalzulli, MD, Calafiore Valeria, MD, Attilio Olivieri, MD, Giovanni Tripepi, PhD

Blood (2015) 126 (23): 4305.

https://doi.org/10.1182/blood.V126.23.4305.4305

Published: 2015

Journal Articles

Gvhd-Associated Early Impairment of Marrow Function Is Frequent after Allogeneic Transplantation and Is a Sensitive Biomarker for Prediction of Treatment Related Mortality and of Overall Survival

Giuseppe Milone, MD, Giuseppe Avola, Maria Grazia Camuglia, Salvatore Leotta, MD, Alessandra Cupri, Andrea Spadaro, MD, Giovanni Tripepi, MD

Blood (2014) 124 (21): 1160.

https://doi.org/10.1182/blood.V124.21.1160.1160

Published: 2014

Journal Articles

Plerixafor On Demand Associated With Chemotherapy and G-CSF: Interim Analysis Of a Prospective Study Shows Significant Improvement In PBSC Mobilization and Harvest With No Increase In Costs

Giuseppe Milone, MD, Massimo Martino, MD, Potito R Scalzulli, M.D., Andrea Spadaro, MD, Valentina Di Martina, MD, Elena Schinocca, MD, Eleonora Spina, MD, Annalia Di Marco, BS, Alessandra Cupri, Giovanni Tripepi, MD, Salvatore Leotta, MD

Blood (2013) 122 (21): 4509.

https://doi.org/10.1182/blood.V122.21.4509.4509

Published: 2013

Journal Articles

High BCR-ABL/GUS IS Levels At Diagnosis Are Associated With Unfavorable Responses To Imatinib

Blood (2013) 122 (21): 1495.

https://doi.org/10.1182/blood.V122.21.1495.1495

Published: 2013

Journal Articles

Myeloid-Derived Suppressor Cells Increase in Chronic Myeloid Leukemia and Exert Immune Suppressive Activity.

Cesarina Giallongo, Nunziatina Parrinello, Daniele Tibullo, Piera La Cava, Alessandra Cupri, MD, PhD, Annalisa Chiarenza, MD, PhD, Fabio Stagno, Giuseppe A Palumbo, Francesco Di Raimondo

Blood (2012) 120 (21): 2779.

https://doi.org/10.1182/blood.V120.21.2779.2779

Published: 2012

Journal Articles

High BCR-ABL Levels At Diagnosis Are Associated with Unfavorable Responses to Imatinib Mesylate.

Blood (2012) 120 (21): 2790.

https://doi.org/10.1182/blood.V120.21.2790.2790

Published: 2012

Journal Articles

BCR-ABL IS Expression at Diagnosis and After 3 or 6 Months of Treatment Predicts CML Response to IMATINIB Therapy.

Paolo Vigneri, MD, PhD, Fabio Stagno, MD, Stefania Stella, PhD, Alessandra Cupri, MD, PhD, Michele Massimino, PhD, Agostino Antolino, MD, Vincenzo Abbadessa, MD, Maura Brugiatelli, MD, Patrizia Guglielmo, MD, Caterina Musolino, MD, Diamante Turri, MD, Mario Russo, MD, Guido Pagnucco, MD, Michele Rizzo, MD, Maurizio Musso, MD, Fortunato Morabito, MD, Luciano Levato, Angelo Messina, MD, Francesco Di Raimondo, MD

Blood (2010) 116 (21): 3426.

https://doi.org/10.1182/blood.V116.21.3426.3426

Published: 2010

Journal Articles

Sustained Responses and Resistance to Imatinib Mesylate in the First 173 Chronic Myeloid Leukemia Patients Accrued by the SCREEN Multicenter Study: First Interim Report.

Blood (2009) 114 (22): 4276.

https://doi.org/10.1182/blood.V114.22.4276.4276

Published: 2009

Journal Articles

The Methylation Status of p21 Is Not Relevant in Adult Acute Lymphoblastic Leukemia Patients.

Blood (2005) 106 (11): 4552.

https://doi.org/10.1182/blood.V106.11.4552.4552

Published: 2005

NARROW

An Acute Gvhd Classification Based on the Dynamic of Gvhd Skin Involvement from Its Appearance to Start of Systemic Treatment

Isavuconazole Prophylaxis during Early Phases of Allogeneic HSC Transplantation Is Not Associated to an Increase Need of Cyclosporin-a Dose Modification

Red Cell Distribution Width (RDW) As Prognostic Factor in Acute Leukemia Patients Undergoing Allogeneic Hematopoietic Transplantation

High Level of IL-2-Receptor and of TIM-3 in Plasma at Day +18 after Allogeneic Transplantation Can Identify Early Patients at Risk for Treatment Related Mortality

High BCR-ABL/GUS IS Levels at Diagnosis Are Associated with Unfavorable Responses to Standard Dose Imatinib

Results and Cost Effectiveness of "on-Demand" Plerixafor Added to Chemotherapy and Granulocyte Colony-Stimulating Factor for Peripheral Blood Stem Cell Mobilization in Multiple Myeloma

Gvhd-Associated Early Impairment of Marrow Function Is Frequent after Allogeneic Transplantation and Is a Sensitive Biomarker for Prediction of Treatment Related Mortality and of Overall Survival

Plerixafor On Demand Associated With Chemotherapy and G-CSF: Interim Analysis Of a Prospective Study Shows Significant Improvement In PBSC Mobilization and Harvest With No Increase In Costs

High BCR-ABL/GUS IS Levels At Diagnosis Are Associated With Unfavorable Responses To Imatinib

Myeloid-Derived Suppressor Cells Increase in Chronic Myeloid Leukemia and Exert Immune Suppressive Activity.

High BCR-ABL Levels At Diagnosis Are Associated with Unfavorable Responses to Imatinib Mesylate.

BCR-ABL IS Expression at Diagnosis and After 3 or 6 Months of Treatment Predicts CML Response to IMATINIB Therapy.

Sustained Responses and Resistance to Imatinib Mesylate in the First 173 Chronic Myeloid Leukemia Patients Accrued by the SCREEN Multicenter Study: First Interim Report.

The Methylation Status of p21 Is Not Relevant in Adult Acute Lymphoblastic Leukemia Patients.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only